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Abstract 
Objective: The aim of this study is to investigate factors associated with poor blood pressure (BP) control in older 
hypertensive patients living in Iran. Poorly controlled hypertension was defined as blood pressure greater than or 
equal to 140/90 mmHg. Multiple logistic regressions were performed to identify factors associated with poor BP 
control.
Results: More than half of the patients (55.1%) had poor control of hypertension. Multivariate logistic regression 
analysis showed that being over 60 years of age (OR 1.67; 95% CI 1.18–2.37; p = .003), being widowed or divorced 
(OR 1.56; 95% CI 1.03–2.35; p = .035], smoking (OR 1.78; 95% CI 1.07–2.65; p = .01], BMI > 25 kg/m2 (OR 1.51 95% 
CI 1.05–2.78), having a waist circumference ≥ 90 cm (OR 1.7; 95% CI 1.2–2.42; p = .003], the use of calcium channel 
blockers (OR 2.69; 95% CI 1.26–5.72; p = .01], and the use of angiotensin converting enzyme inhibitors (OR 1.66; 95% 
CI 1.01–2.72; p = .044] contributed significantly to poor control of hypertension. Making a key BP control screening 
target (such as age over 60 and waist circumference of 90 cm or more) for cardiovascular specialists and other health 
care practitioners is needed for elderly patients at risk for poor BP control.
Keywords: Hypertension, Uncontrolled blood pressure, Patient, Cardiovascular diseases
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Hypertension is a common risk factor for cardiovascular 
disease and is a major health problem around the world. 
In addition, it is the most important single contributor 
to premature mortality [1–3]. It has been estimated that 
22.1% of Iranian adults are hypertensive, and in most 
cases, their blood pressure is uncontrolled [4].
Poor control of blood pressure could augment cardio-
vascular risks, stroke, and myocardial infarction, which 
can be catastrophic to individuals and results in increas-
ing costs for health care systems [5]. The role of systolic 
blood pressure (SBP) as an important predictor for car-
diovascular risk has been demonstrated in several stud-
ies [6]. For instance, a recent study provided evidence 
that each 10 mmHg reduction in usual SBP is associated 
with a significant 11% reduction in the risk of myocardial 
infarction [7].
Because the need to control and to manage hyperten-
sion is well recognized, primary health care systems 
are on the front lines. They can provide screening pro-
grams for early detection, manage regular contacts with 
patients, apply preventive measures, and deliver consist-
ent and persistent care for patients with hypertension 
[8]. However, it is important to identify the factors that 
influence BP control in hypertensive patients. Previous 
studies found that low adherence to medication use [9], 
an unhealthy lifestyle [10], competing priorities, and pro-
vider inertia [11] contribute to the poor control of BP. 
On the other hand, screening, diagnosis, treatment, and 
successful control of hypertension are difficult to catch, 
especially among older hypertensive patients. Adding 
another level of complexity to this public health prob-
lem, demographic variation and increasing prevalence of 
hypertension by age make this condition one of the major 
health policy challenges [12]. Approximately 50% of 
patients with hypertension drop out of health care within 
the first year of diagnosis, and only 25–34% of them com-
ply with antihypertensive treatment and have controlled 
BP [13].
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It is therefore important to identify factors that could 
affect BP control among older hypertensive patients. The 
aim of this study is to investigate factors that may influ-
ence poor BP control in older hypertensive patients and 
to identify patients’ characteristics associated with poor 
control of BP in order to improve the management and 
care of these patients.
Main text
Methods
This cross-sectional study was conducted in Takab, West 
Azerbaijan province, Iran. A total of 750 patients with a 
diagnosis of hypertension in primary health care centers 
were randomly recruited from August 2016 to February 
2017. The inclusion criteria were: (1) having been diag-
nosed with hypertension in the previous 6  months, (2) 
being 50 years old or above, and (3) having a household 
health record in one of the Takab health care centers. 
Subjects who have diabetes and a cognitive disorder were 
not eligible.
Patients who had been referred to health care centers 
were randomly selected and contacted by telephone for 
eligibility. During the phone interview, eligible patients 
who were interested in participating in the study were 
asked to come to the health centers for a clinical assess-
ment by a trained health care researcher. The response 
rate was 83.3% (750/900).
Data were collected by administering a questionnaire. 
The questions related to the participants’ sociodemo-
graphic characteristics, treatment for hypertension, 
medical history, and current cigarette smoking habits fol-
lowed the guidelines provided by the American college 
of cardiology [14]. Furthermore, patients’ blood pres-
sure (BP), waist circumference (WC), weight, and body 
mass index (BMI) were also recorded. BP was measured 
with a mercury sphygmomanometer, twice in the same 
arm, after the participant had been seated at rest for 
10–15 min. The systolic and diastolic BP measurements 
were the mean of the two readings. WC was evaluated 
using a measuring tape to the nearest .1 cm. The weight 
of an individual dressed in light clothing without shoes 
was recorded each time using a calibrated scale to the 
nearest .1 kg. Height was measured without shoes using 
a stadiometer to the nearest .1 cm. BMI was measured by 
the individual’s weight in kilograms divided by the square 
of his/her height in meters [15].
Consistent with [16], uncontrolled hypertension was 
defined as systolic blood pressure ≥  140  mmHg and/or 
diastolic blood pressure  ≥  90  mmHg for patients that 
currently taking antihypertensive medication. Antihyper-
tensive treatment information was asked from patients 
and in the absence of patients information, it was derived 
from household health records (Additional file 1).
Statistical analyses were conducted using the STATA 
release 14.0 software (College Station, Texas, USA). 
Data were presented using frequencies (percentages) for 
categorical variables and means for numeric variables. 
Descriptive statistics were calculated to compare the 
characteristics of patients with controlled and uncon-
trolled hypertension. Between-group differences were 
calculated using χ2 or Student’s t tests. A series of t tests 
and multiple logistic regressions were performed to com-
pute odds ratios (ORs) and their confidence intervals. In 
the univariate analyses, demographic and anthropomet-
ric factors were entered separately. p values below .05 
were considered to be significant.
Results
The sociodemographic and clinical characteristics of the 
hypertensive patients are shown in Table  1. The mean 
age of the 750 patients was 65.4  years, and 56.1% were 
women. More than half (55%, n  =  413) of the patients 
had uncontrolled hypertension. There were significant 
marital status differences between patients with con-
trolled and uncontrolled BP. Significant differences 
between patients with controlled and uncontrolled 
hypertension were found for BMI, weight, WC, years liv-
ing with hypertension and comorbidities in hypertension 
(p < .05 for all).
Table  2 provides information about patients’ medica-
tion use based on antihypertensive drug class. The most 
common medications used are angiotensin converting 
enzyme inhibitors (ACEIs, 37.9% of the patients), fol-
lowed by angiotensin receptor blockers (ARBs, 14.9%), 
β-blockers (12.4%), diuretics (9.7%), and calcium channel 
blockers (CCBs, 3.9%). Almost all patients (99.9%) were 
receiving antihypertensive medication, and only 44% of 
the patients achieved controlled BP.
The results of the multivariate analyses of factors pre-
dicting poor BP control are shown in Table 3. Multivari-
ate logistic regression analysis showed that the following 
factors were significantly associated with uncontrolled 
blood pressure control: being 60 years old or above (OR 
1.67; 95% CI 1.18–2.37; p  =  .003), being widowed or 
divorced (OR 1.56; 95% CI 1.03–2.35; p =  .035), smok-
ing (OR 1.69; 95% CI 1.07–2.65; p = .023), BMI > 25 kg/
m2 (OR 1.51 95% CI 1.05–2.78), having a waist circum-
ference of 90  cm or more (OR 1.7; 95% CI 1.2–2.42; 
p  =  .003), using CCBs (OR 2.69; 95% CI 1.26–5.72; 
p =  .01), and using ACEIs (OR 1.66; 95% CI 1.01–2.72; 
p = .044).
Discussion
The study presents an analysis of factors that may be 
associated with poor BP control in hypertensive patients 
in Takab, West Azerbaijan province, Iran. The findings 
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from this study revealed that only 44.9% of the patients 
had adequate BP control [16]. A similar study from 
China indicated that nearly 95% of patients were receiv-
ing antihypertensive medication, and that only 16.7% 
of women and 19.1% of men had adequate BP control 
[17]. Although adequate control of BP is a cornerstone 
in stroke prevention and coronary events, our findings 
indicate that BP control cannot be achieved by more than 
half of the patients (55.1%). The rates of control of hyper-
tensive patients in our study were higher than the 48% 
control rate in the United States of America that reported 
in a NHANES study [18]. Therefore, it is important to 
identify factors that influence poor BP control among 
hypertensive patients.
Results from the multivariate logistic regression 
analysis revealed that being older than 60  years, being 
Table 1 Descriptive characteristics of hypertensive patients
Parameters Controlled BP Uncontrolled BP Total p value
Categorical variables N (%) N (%) N (%)
Gender 337 413 .980
 Male 148 (43.9) 181 (43.8) 329 (43.9)
 Female 189 (56.1) 232 (56.2) 421 (56.1)
Marital status .048
 Married 275 (81.6) 304 (73.6) 579 (77.2)
 Single 4 (1.2) 2 (.48) 6 (.8)
 Widow 55 (16.3) 100 (24.2) 155 (20.66)
 Divorced 3 (.9) 7 (1.7) 10 (1.3)
Education .207
 Illiterate 237 (81.6) 311 (75.3) 548 (73.1)
 Elementary school 90 (26.7) 97 (23.5) 187 (24.9)
 High school and university 6 (1.8) 3 (.7) 9 (1.2)
Economic status .671
 Low 147 (43.6) 168 (40.6) 315 (42)
 Intermediate 139 (41.2) 177 (42.8) 316 (42.1)
 High 51 (15.2) 68 (16.4) 119 (15.8)
Comorbidities of hypertension (yes) 72 (21.3) 130 (31.4) 202 (26.9) .002
 Mental 9 (12.5) 20 (15.4) 29 (14.3)
 Coronary Heart Disease 26 (31.7) 56 (68.3) 82 (40.6)
 Cancer 0 2 (1.5) 2 (.9)
 Respiratory diseases 12 (16.6) 21 (16.2) 33 (16.3)
 Urologic diseases 6 (8.3) 5 (3.8) 11 (5.4)
 Arthritis 12 (16.6) 17 (13.1) 29 (14.3)
 Thyroid disease 1 (1.3) 1 (.7) 2 (.9)
 Osteoporosis 2 (2.6) 2 (1.4) 4 (1.8)
 Eye diseases 1 (1.3) 3 (2.3) 4 (1.8)
 Gastritis 3 3 (2.3) 6 (2.9)
Parameters Controlled BP Uncontrolled BP Total p value
Continuous variables Mean (SD) Mean (SD) Mean (SD)
 Age (years) 64.7 (9.8) 65.9 (9.5) 65.4 (9.7) .094
 BMI (kg/m2) 26 (4.4) 27.4 (4.5) 26.8 (4.5) < .0001
 Weight (kg) 67.5 (12.2) 70.9 (12.5) 69.36 (12.5) < .0001
 WC 92.5 (12.3) 96.9 (11) 94.8 (12.6) < .0001
 SBP (mmHg) 125.9 (8.7) 147.1 (15.5) 137.6 (16.6) < .0001
 DBP (mmHg) 77.4 (6) 92.2 (8.8) 85.5 (10.6) < .0001
 Years living with hypertension 7.6 (4.4) 8.4 (4.4) 8.04 (4.5) .018
BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure
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widowed or divorced, smoking, having a waist circumfer-
ence of 90 cm or more, the use of CCBs, and the use of 
ACEIs contribute to poor control of hypertension. The 
finding that being 60 years old or above is associated with 
higher odds of uncontrolled BP is consistent with previ-
ous studies [19]. One major reason for this poor manage-
ment of BP is that the severity of hypertension increases 
markedly with advancing age [20]. Furthermore, because 
BP control is difficult in elderly patients and represents a 
management dilemma, it seems that categorizing hyper-
tensive patients into ≥ 60 and < 60 years might be a key 
BP control screening target for cardiovascular specialists 
and other practitioners in health care settings. Ideally, 
older patients with hypertension should be followed up 
on every 3–6 months and continue to assess their adher-
ence to medication use for BP control [21]. Also, more 
efforts, such as public health education and a blood pres-
sure monitoring system, should be included for the older 
age group.
In this study, we found a significant association 
between poor BP control and being widowed or 
divorced, which is consistent with other studies [22, 23]. 
This finding may be related to the absence of partner 
support, which often results in lower health outcomes 
through health risk behaviors and stress [22]. Consist-
ent with our results, Idler et al. [15] highlighted a strong 
protective effect of spouses in caregiving (both male and 
female) on survival for up to 5  years following surgery. 
This suggests that social spousal support, more so than 
lifestyle behaviors and medicine use, produces health 
benefits. Social support can benefit patients’ health by 
buffering stress, improving self-efficacy, and increasing 
healthy behavior [9, 24]. In fact, a meta-analysis study 
found that adherence was 27% higher when patients had 
practical support available to them. However, inconsist-
ent with our results, there is also evidence that a spouse 
or partner does not reduce uncontrolled hypertension, 
suggesting that further research is needed regarding the 
role of spouses in the management of hypertension con-
ditions [25].
Another factor that affected poor BP control is smok-
ing. This result confirms that smoking acutely increases 
blood pressure due to an increase in both cardiac output 
and total peripheral vascular resistance [26]. Alterna-
tively, smoker patients are more sedentary and have less 
healthy diets, both of which are factors that can directly 
raise BP and result in failure in BP control [27].
The relationship between waist circumference and 
hypertension has been clearly established [28]. In the 
present study, the likelihood of poor BP control was 
increased when the waist circumference was 90  cm or 
more (i.e., the cut-off point for the Iranian abdominal 
obesity definition) [29]. According to the findings of our 
study, an increase in waist circumference significantly 
increases the probability of poor BP control. This find-
ing confirms that the impact of abdominal obesity on the 
Table 2 Medication use among hypertensive patients 
based on antihypertensive drug class
ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, 
CCB calcium channel blockers
Medication use Controlled BP Uncontrolled BP Total
337 413 (55.1) 750
CCB 10 (34.5) 19 (65.5) 29
ACEI 111 (39.1) 173 (60.9) 284
β-blockers 43 (46.2) 50 (53.8) 93
ARB 58 (51.8) 54 (48.2) 112
Diuretics 45 (61.6) 28 (38.4) 73
Diuretics + ARB 8 (28.6) 20 (71.4) 28
Diuretics + CCB 2 (20) 8 (80) 10
Diuretics + ARB + ACEI 4 (36.4) 7 (63.6) 11
β-blockers + ACEI 24 (66.7) 12 (33.3) 36
β-blockers + ARB 5 (31.3) 11 (68.8) 16
β-blockers + Diuretics 12 (63.2) 7 (36.8) 19
Diuretics + ACEI 13 (41.9) 18 (58.1) 31
ACEI + CCB 1 (14.3) 6 (85.7) 7
Table 3 Multivariate model predicting blood pressure 
control among patients with hypertension
ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, 
CCB calcium channel blockers
OR 95% CI p value
Age in years (ref ≤ 60)
 > 60 1.67 1.18–2.37 .003
Gender (ref = female)
 Male .79 .85–1.98 .226
Married status (ref = married)
 Single .54 .084–3.5 .522
 Widowed/divorced 1.56 1.03–2.35 .035
Smoking (yes) 1.78 1.07–2.65 .010
Comorbidity 1.32 .77–2.46 .329
Weight 1.01 .99–1.03 .21
BMI (ref ≤ 25 kg/m2)
 26–30 kg/m2 1.51 1.05–2.78 .025
 > 30 kg/m2 1. 63 1.02–2.61 .040
Waist circumference in cm (ref ≤ 90)
 ≥ 90 1.7 1.2–2.42 .003
Living with hypertension 1.24 .76–2.01 .39
Medication use
 CCB 2.69 1.26–5.72 .01
 ACEI 1.66 1.01–2.72 .044
 β-blockers 1.037 .62–1.7 .89
 ARB 1.36 .84–2.21 .2
 Diuretics .94 .57–1.55 .82
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control of hypertension is an important risk factor [30, 
31].
All of the patients had been treated with antihyper-
tensive drugs for an average of 8.04 years prior to study 
enrollment. Our findings suggest that poor control of 
blood pressure is also significantly associated with the 
use of CCBs and ACEIs, which is consistent with the 
findings of a study by Xu et al. [17]. However, some stud-
ies have shown improvements in the outcomes among 
patients with coronary heart disease using dihydropyri-
dine CCBs [32, 33]. Although non-dihydropyridine CCBs 
are taken more often by uncontrolled than controlled 
hypertensive patients, they have marked negative ino-
tropic effects [34]. Consistent with a previous study [34], 
our findings align with the efficacy of diuretics and renin-
angiotensin system blockers, especially when they are 
taken in combination.
Hypertension surveillance could be used more fre-
quently in daily practice in primary care to identify at-risk 
individuals. As such, it is important to make hypertensive 
patients and their families aware of the risk factors of 
uncontrolled BP. The results of the present study indicate 
the need for greater efforts at safe, effective strategies in 
order to achieve controlled BP among the oldest patients 
with hypertension. BP control may be related to factors 
beyond medication adherence, including lifestyle factors, 
social support, and the ability to navigate the health care 
system effectively, though this requires further study. In 
addition, the failure of antihypertensive medication to 
adequately control BP is determined by both the patients’ 
characteristics and factors related to the medication. 
The findings of this study indicate that treating elderly 
hypertensive patients will reduce the risk of cardiovas-
cular events. There is evidence that hypertension treat-
ment reduces the incidence of cognitive impairment and 
dementia in the elderly [35].
Limitations
This study was cross-sectional, and could not determine 
causality. Another limitation was potential measurement 
error for the medication use. There wasn’t any informa-
tion on actual adherence to high blood pressure medica-
tion use and treatment.
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